Integra LifeSciences (IART) News Today $15.83 +0.08 (+0.51%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$15.87 +0.04 (+0.25%) As of 04/17/2025 05:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Geode Capital Management LLC Sells 247,336 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)Geode Capital Management LLC reduced its holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 13.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,576,658 shares of the life sciences companyApril 19 at 3:25 AM | marketbeat.comIntegra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025April 18 at 4:30 PM | globenewswire.comLSV Asset Management Acquires 29,300 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)LSV Asset Management increased its holdings in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 14.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 237,900 shares of the lifeApril 16, 2025 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Price Target Lowered to $19.00 at Truist FinancialApril 14, 2025 | americanbankingnews.comIntegra LifeSciences (NASDAQ:IART) Reaches New 52-Week Low on Analyst DowngradeIntegra LifeSciences (NASDAQ:IART) Sets New 52-Week Low Following Analyst DowngradeApril 14, 2025 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Stock Price Down 7.8% After Analyst DowngradeIntegra LifeSciences (NASDAQ:IART) Shares Down 7.8% Following Analyst DowngradeApril 13, 2025 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Given New $19.00 Price Target at Truist FinancialTruist Financial dropped their target price on Integra LifeSciences from $26.00 to $19.00 and set a "hold" rating for the company in a research report on Friday.April 13, 2025 | marketbeat.comExodusPoint Capital Management LP Buys Shares of 48,332 Integra LifeSciences Holdings Co. (NASDAQ:IART)ExodusPoint Capital Management LP bought a new stake in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 48,332 shares of the life sciences company's stockApril 13, 2025 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Trading Down 7.8% on Analyst DowngradeApril 13, 2025 | americanbankingnews.comIntegra LifeSciences (NASDAQ:IART) Reaches New 1-Year Low Following Analyst DowngradeApril 12, 2025 | americanbankingnews.comIntegra LifeSciences price target lowered to $19 from $26 at TruistApril 12, 2025 | markets.businessinsider.comNorges Bank Acquires New Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART)Norges Bank bought a new position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 395,385 shares of the life sciences company's sApril 10, 2025 | marketbeat.comDo Options Traders Know Something About Integra (IART) Stock We Don't?April 9, 2025 | msn.comOrion Portfolio Solutions LLC Invests $728,000 in Integra LifeSciences Holdings Co. (NASDAQ:IART)Orion Portfolio Solutions LLC bought a new stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 32,109 shares of the life scApril 8, 2025 | marketbeat.comVanguard Group Inc. Trims Stake in Integra LifeSciences Holdings Co. (NASDAQ:IART)Vanguard Group Inc. lessened its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 2.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 7,580,967 shares of the life sciences company's sApril 8, 2025 | marketbeat.comWellington Management Group LLP Reduces Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART)Wellington Management Group LLP lowered its position in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 77.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,506,138 shares ofApril 7, 2025 | marketbeat.comAlliancebernstein L.P. Lowers Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART)Alliancebernstein L.P. reduced its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 14.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,578,393 shares of theApril 7, 2025 | marketbeat.com15,100 Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) Purchased by KLP Kapitalforvaltning ASKLP Kapitalforvaltning AS purchased a new stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 15,100 shares of the life sciences company's sApril 7, 2025 | marketbeat.comPrudential Financial Inc. Lowers Position in Integra LifeSciences Holdings Co. (NASDAQ:IART)Prudential Financial Inc. lessened its holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 57.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 88,121 shares of the life sciencesApril 6, 2025 | marketbeat.comRaymond James Financial Inc. Invests $943,000 in Integra LifeSciences Holdings Co. (NASDAQ:IART)Raymond James Financial Inc. bought a new stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 41,592April 6, 2025 | marketbeat.com156,746 Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) Purchased by Cannell & Spears LLCCannell & Spears LLC acquired a new stake in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 156,746 shares of the life sciences company's stock, valued at approximately $3,555,0April 2, 2025 | marketbeat.comIntegra LifeSciences Holdings Co. (NASDAQ:IART) Given Consensus Rating of "Reduce" by AnalystsShares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Get Free Report) have earned a consensus rating of "Reduce" from the eight ratings firms that are presently covering the stock, MarketBeat reports. Three equities research analysts have rated the stock with a sell rating, four have issuedApril 1, 2025 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Stock Rating Upgraded by ArgusArgus upgraded Integra LifeSciences from a "hold" rating to a "buy" rating in a research report on Monday.April 1, 2025 | marketbeat.comArgus upgrades Integra to Buy, says well-positioned for a turnaroundApril 1, 2025 | markets.businessinsider.comIntegra LifeSciences upgraded to Buy from Hold at ArgusApril 1, 2025 | markets.businessinsider.comArgus Research Upgrades Integra LifeSciences Holdings (IART)April 1, 2025 | msn.comIntegra LifeSciences Holdings C (IART) Stock ForecastsApril 1, 2025 | finance.yahoo.comQuantbot Technologies LP Sells 64,470 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)Quantbot Technologies LP reduced its holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 89.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 7,881 shares of the life sciences company's stock after selling 64,470March 31, 2025 | marketbeat.comIntegra LifeSciences Holdings Co. (NASDAQ:IART) Shares Purchased by Thrivent Financial for LutheransThrivent Financial for Lutherans raised its holdings in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 70.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 93,427 shares of the life sciences compMarch 30, 2025 | marketbeat.comIntegra (IART) Down 7.5% Since Last Earnings Report: Can It Rebound?March 27, 2025 | msn.comIntech Investment Management LLC Has $547,000 Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART)Intech Investment Management LLC lifted its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 86.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 24,113 shares of thMarch 25, 2025 | marketbeat.comQ4 Earnings Review: Surgical Equipment & Consumables - Specialty Stocks Led by Intuitive Surgical (NASDAQ:ISRG)March 24, 2025 | msn.comNotice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your BehalfMarch 22, 2025 | globenewswire.comIntegra LifeSciences (NASDAQ:IART) Shares Down 2.9% - Here's What HappenedIntegra LifeSciences (NASDAQ:IART) Trading Down 2.9% - Here's WhyMarch 20, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Decreases Stake in Integra LifeSciences Holdings Co. (NASDAQ:IART)Connor Clark & Lunn Investment Management Ltd. lessened its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 76.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5March 20, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Increases Position in Integra LifeSciences Holdings Co. (NASDAQ:IART)Charles Schwab Investment Management Inc. increased its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 10.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,047,573 shareMarch 19, 2025 | marketbeat.com3 Reasons IART is Risky and 1 Stock to Buy InsteadMarch 14, 2025 | msn.comIntegra LifeSciences Holdings Co. (NASDAQ:IART) Position Lowered by Bank of New York Mellon CorpBank of New York Mellon Corp reduced its position in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 3.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 467,962 shares of the life scienceMarch 14, 2025 | marketbeat.comIntegra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services ConferenceMarch 13, 2025 | globenewswire.comIntegra LifeSciences (NASDAQ:IART) Stock Price Down 4.3% - Here's WhyIntegra LifeSciences (NASDAQ:IART) Stock Price Down 4.3% - Should You Sell?March 13, 2025 | marketbeat.comInceptionr LLC Makes New $351,000 Investment in Integra LifeSciences Holdings Co. (NASDAQ:IART)Inceptionr LLC purchased a new position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 15,491 shares of theMarch 10, 2025 | marketbeat.comIntegra LifeSciences: Light At The End Of The Tunnel, Or Another Oncoming Train? (Rating Upgrade)March 6, 2025 | seekingalpha.comFisher Asset Management LLC Decreases Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART)Fisher Asset Management LLC reduced its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 88.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 47,198 shares of the life sciences company'March 6, 2025 | marketbeat.comPrincipal Financial Group Inc. Buys 22,000 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)Principal Financial Group Inc. grew its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 5.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 423,432 shares of the life sciences company's stock after bMarch 1, 2025 | marketbeat.comTruist Financial Remains a Hold on Integra Lifesciences (IART)February 26, 2025 | markets.businessinsider.comBTIG Remains a Hold on Integra Lifesciences (IART)February 26, 2025 | markets.businessinsider.comINTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Integra LifeSciences Holdings Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmFebruary 25, 2025 | globenewswire.comIntegra LifeSciences sees 2025 adjusted EPS $2.41-$2.51, consensus $2.51February 25, 2025 | markets.businessinsider.comIntegra LifeSciences (NASDAQ:IART) Misses Q4 Revenue EstimatesFebruary 25, 2025 | msn.comIntegra LifeSciences Holdings Corporation 2024 Q4 - Results - Earnings Call PresentationFebruary 25, 2025 | seekingalpha.com Get Integra LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter. Email Address IART Media Mentions By Week IART Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IART News Sentiment▼0.560.58▲Average Medical News Sentiment IART News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IART Articles This Week▼85▲IART Articles Average Week Get Integra LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ITGR News ATRC News ATEC News OFIX News SRDX News ANGO News ARAY News RMTI News RSLS News ABT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IART) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integra LifeSciences Holdings Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Integra LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.